Growth Metrics

Acadia Pharmaceuticals (ACAD) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -10.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 26.38%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -46.86%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.80%
7 Evaxion A 64.16 Bn 64.14 Bn - 34.98%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 47.10%
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn 27.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.74%
Dec 31, 2025 104.60%
Sep 30, 2025 66.82%
Jun 30, 2025 40.69%
Mar 31, 2025 29.42%
Dec 31, 2024 74.74%
Sep 30, 2024 62.19%
Jun 30, 2024 40.29%
Mar 31, 2024 31.02%
Dec 31, 2023 39.04%
Sep 30, 2023 8.35%
Jun 30, 2023 26.54%
Mar 31, 2023 21.23%
Dec 31, 2022 7.72%
Sep 30, 2022 13.50%
Jun 30, 2022 14.81%
Mar 31, 2022 -9.84%
Dec 31, 2021 13.04%
Sep 30, 2021 38.50%
Jun 30, 2021 11.49%
Mar 31, 2021 -6.96%
Dec 31, 2020 1.13%
Sep 30, 2020 -9.07%
Jun 30, 2020 14.51%
Mar 31, 2020 -0.07%
Dec 31, 2019 11.82%
Sep 30, 2019 16.31%
Jun 30, 2019 8.33%
Mar 31, 2019 -19.68%
Dec 31, 2018 -44.77%
Sep 30, 2018 -16.89%
Jun 30, 2018 -17.12%
Mar 31, 2018 -10.38%
Dec 31, 2017 -59.53%
Sep 30, 2017 -38.08%
Jun 30, 2017 -46.40%
Mar 31, 2017 -70.16%
Dec 31, 2016 -98.29%
Sep 30, 2016 -88.48%
Jun 30, 2016 -98.78%
Mar 31, 2016 -101.05%
Dec 31, 2015 124.43%
Sep 30, 2015 -153.02%
Jun 30, 2015 -93.69%
Mar 31, 2015 -86.56%
Dec 31, 2014 102.52%
Sep 30, 2014 -69.65%
Jun 30, 2014 -48.56%
Mar 31, 2014 -45.12%
Dec 31, 2013 -22.92%
Sep 30, 2013 -36.26%